Levofloxacin, sold under the trade names Levaquin among others, is an antibiotic. It is used to treat a number of bacterial infections including acute bacterial sinusitis, pneumonia, urinary tract infections, chronic prostatitis, and some types of gastroenteritis. Along with other antibiotics it may be used to treat tuberculosis, meningitis, or pelvic inflammatory disease. It is available by mouth, intravenously, and in eye drop form.
Factors such as increasing incidences of bacterial infections such as pneumonia & urinary tract infections (UTI) and broad spectrum efficacy drive the market growth.
However, side effects associated with levofloxacin such as tendon inflammation, psychosis, and seizures restrain the market growth.
Furthermore, rising geriatric population and growing initiatives by the government to spread awareness about severe infections are expected to further drive the market growth.
In 2017, the global Levofloxacin market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Levofloxacin market based on company, product type, application and key regions.
This report studies the global market size of Levofloxacin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Levofloxacin in these regions.
This research report categorizes the global Levofloxacin market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
The various contributors involved in the value chain of Levofloxacin include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Levofloxacin include
Alna Biotech Private
Allenge India Pharma
Divine Savior Healthcare
Dr. Reddys Laboratories
Market Size Split by Type
Market Size Split by Application
Market size split by Region
Central & South America
Rest of Central & South America
Middle East & Africa
The study objectives of this report are:
To study and analyze the global Levofloxacin market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Levofloxacin market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Levofloxacin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Levofloxacin with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Levofloxacin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Levofloxacin are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Levofloxacin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.